Prince Pharmaceutical Co., Ltd.

6935

TW0006935000

Food Processing

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
27.2 ^TWD	-2.33%		-2.68%	-22.29%

Mar. 25	Prince Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Prince Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Prince Pharmaceutical Co., Ltd. has filed an IPO in the amount of TWD 90 million.

November 10, 2022 at 12:00 am EST

Prince Pharmaceutical Co., Ltd. has filed an IPO in the amount of TWD 90 million.

Security Name: Shares
Security Type: Common Stock
Securities Offered: 3,000,000
PriceRange: TWD 30

Latest news about Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Prince Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-09	CI
Prince Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-21	CI
Prince Pharmaceutical Co., Ltd. has completed an IPO in the amount of TWD 90 million.	23-03-30	CI
Prince Pharmaceutical Co., Ltd. has filed an IPO in the amount of TWD 90 million.	22-11-10	CI

Chart Prince Pharmaceutical Co., Ltd.

Duration

Period

More charts

Prince Pharmaceutical Co Ltd is a Taiwan-based Company engaged in the manufacture and sale of health food and ingredients. The Company's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs. The health food business is mainly engaged in the original equipment manufacturer (OEM) and original design manufacturer (ODM) of health food products, providing a series of integrated services from product formulation design, research and development to the production and packaging of various dosage forms. The Company sells its products mainly in domestic and overseas markets, including Japan and Korea.

Sector

Food Processing

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
PRINCE PHARMACEUTICAL CO., LTD.	-22.29%	30.39M
ZHEJIANG NHU COMPANY LTD.	+9.79%	7.89B
BELLRING BRANDS, INC.	+2.60%	7.2B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-2.68%	5.75B
THE SIMPLY GOOD FOODS COMPANY	-8.03%	3.64B
BYHEALTH CO., LTD	-14.39%	3.42B
XIAMEN KINGDOMWAY GROUP COMPANY	-15.43%	1.16B
HERBALIFE LTD.	-28.11%	1.1B
SIRIO PHARMA CO., LTD.	+5.08%	906M
USANA HEALTH SCIENCES, INC.	-16.12%	857M